Novel Technologies News for July 2009

Novel Technologies News Archive

Obesity intervention device receives approval for weight loss that leads to improvement or remission of type 2 diabetes Obesity intervention device receives approval for weight loss that leads to improvement or remission of type 2 diabetes

Obesity, defined as having a BMI of 30 or greater, and type 2 diabetes are likely to be the greatest public health problems of the next decade. Type 2 diabetes has reached pandemic proportions, and the risk of developing the disease has increased up to ten times in people who are obese.

Integrated DNA Technologies introduces novel peptide delivery system for dsRNA Integrated DNA Technologies introduces novel peptide delivery system for dsRNA

Integrated DNA Technologies (IDT) has introduced the novel peptide-based double-stranded RNA (dsRNA) transduction delivery system Transductin™.

PerkinElmer sponsors awards recognizing outstanding accomplishments in capillary chromatography PerkinElmer sponsors awards recognizing outstanding accomplishments in capillary chromatography

PerkinElmer, Inc. recently announced the winners of two industry awards for exceptional achievements in capillary chromatography. PerkinElmer presented the Marcel Golay Award to Barry L. Karger, PhD, of Northeastern University for his work in narrow-diameter liquid chromatography (LC) and the Leslie Ettre Award to W. Christopher Siegler of the University of Washington for his work in three-dimensional gas chromatography (GC).

Nematode foreplay caught on camera Nematode foreplay caught on camera

Researchers studying the nervous control of nematode mating behaviour have produced video footage of a male worm preparing to mate with a hermaphrodite.

New nanoparticles could revolutionize therapeutic drug discovery New nanoparticles could revolutionize therapeutic drug discovery

Understanding the structure of proteins is a vital first step in developing new drugs, but to date, drug development has been slow because owing to their instability, proteins are difficult to work with in lab conditions.

Brain imaging (MRI/PET) and measurements of proteins in spinal fluid might improve Alzheimer's prediction and diagnosis Brain imaging (MRI/PET) and measurements of proteins in spinal fluid might improve Alzheimer's prediction and diagnosis

Changes in the brain measured with MRI and PET scans, combined with memory tests and detection of risk proteins in body fluids, might lead to earlier and more accurate diagnosis of Alzheimer’s, according to new research reported recently at the Alzheimer’s Association 2009 International Conference on Alzheimer’s Disease (ICAD 2009) in Vienna.